Formulation Development

  • Pre-formulation Profiling and Drug-ability Assessment
  • Generic Formulation Development
  • Formulation Development for FIH Studies and Various Clinical Phases
  • Pre-clinical Formulation Development
  • Formulation Development for Life Cycle Management (LCM/NDDS)
  • Paediatric Formulation Development
  • Lyophilization Technology
  • Solid Dispersion Technology
  • Granulation TechnologyHigh Shear Techniques, Dry Granulation Technique
  • Fluidized Bed TechnologyWurster Technique, Top Spray Technique
  • Tablet Compression
  • Tablet Coating Technology ( Perforated pan coating)
  • Encapsulation

Solid orals:

Capsules and Tablets: Immediate, delayed, modified, multi-particulate, effervescent, chewable, dispersible etc. tablets dosage forms.

Liquid Orals:

Suspensions (Ready to use & PFOS)
Solution (Ready to use & PFOS)

Parenterals :

Lyophilized products, Injections, Lipids and Peptides, Solutions, prefilled syringes , Etc.

COVID Update
Team IDRS is committed towards working on complex products in niche therapeutic areas to address the unmet medical needs. This extends to the current challenging time, where the entire scientific community is working towards bringing some therapeutic option to provide relief from Covid-19 and associated complications. Our team, in collaboration with some of the premier Indian Institutes, is fervently working on a phytopharmaceutical product that will not only provide an option to treat Covid 19 patients but also minimise post Covid complications. Watch this space for further updates.